Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
McKinsey
Citi
US Department of Justice
AstraZeneca
McKesson
Colorcon
Harvard Business School
Boehringer Ingelheim

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TIOTROPIUM BROMIDE

« Back to Dashboard

Clinical Trials for Tiotropium Bromide

Trial ID Title Status Sponsor Phase Summary
NCT00139932 Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) Completed Integrated Therapeutics Group Phase 4 This study is being conducted to determine if the co-administration of formoterol fumarate and tiotropium bromide is more effective than the use of tiotropium bromide alone in patients with COPD.
NCT00139932 Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) Completed Novartis Phase 4 This study is being conducted to determine if the co-administration of formoterol fumarate and tiotropium bromide is more effective than the use of tiotropium bromide alone in patients with COPD.
NCT00139932 Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) Completed Merck Sharp & Dohme Corp. Phase 4 This study is being conducted to determine if the co-administration of formoterol fumarate and tiotropium bromide is more effective than the use of tiotropium bromide alone in patients with COPD.
NCT00144326 A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (CO Completed Boehringer Ingelheim Phase 3 The objective of this study is to determine if tiotropium (Spiriva, Bromuro de Tiotropio) 18 mcg once daily by oral inhalation compared to placebo increases the magnitude of daily physical activity observed in COPD patients, measured using an accelerometer.
NCT00157235 Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients Completed Boehringer Ingelheim Phase 3 The objective of this trial is to determine whether tiotropium inhalation capsules (Spiriva, Bromuro de Tiotropio), compared to placebo, enhances the improvement in exercise tolerance seen in patients with chronic obstructive pulmonary disease (COPD) who participate in pulmonary rehabilitation.
NCT00239408 Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal). Completed Boehringer Ingelheim Phase 4 Evaluate whether the effect of inhaled tiotropium bromide on the change in trough forced expiratory volume (FEV1), compared to placebo in patients with chronic obstructive pulmonary disease (COPD), is affected by smoking status.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Tiotropium Bromide

Condition Name

Condition Name for Tiotropium Bromide
Intervention Trials
Pulmonary Disease, Chronic Obstructive 49
Chronic Obstructive Pulmonary Disease 20
COPD 10
Asthma 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Tiotropium Bromide
Intervention Trials
Pulmonary Disease, Chronic Obstructive 79
Lung Diseases 75
Chronic Disease 49
Lung Diseases, Obstructive 43
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Tiotropium Bromide

Trials by Country

Trials by Country for Tiotropium Bromide
Location Trials
United States 437
Germany 64
Canada 63
Italy 35
Japan 31
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Tiotropium Bromide
Location Trials
California 25
South Carolina 24
Texas 23
Florida 23
Ohio 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Tiotropium Bromide

Clinical Trial Phase

Clinical Trial Phase for Tiotropium Bromide
Clinical Trial Phase Trials
Phase 4 31
Phase 3 32
Phase 2 21
[disabled in preview] 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Tiotropium Bromide
Clinical Trial Phase Trials
Completed 88
Recruiting 9
Terminated 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Tiotropium Bromide

Sponsor Name

Sponsor Name for Tiotropium Bromide
Sponsor Trials
Boehringer Ingelheim 46
GlaxoSmithKline 15
Novartis 6
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Tiotropium Bromide
Sponsor Trials
Industry 96
Other 41
NIH 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Express Scripts
Queensland Health
UBS
Julphar
Deloitte
Argus Health
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.